Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How lupoid is lupoid hepatitis?

S Hall, A J Czaja, D K Kaufman

    The Journal of Rheumatology
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis.

    Alimentary pharmacology & therapeutics·2017
    Same author

    2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome - author's reply.

    Alimentary pharmacology & therapeutics·2015
    Same author

    Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets.

    Alimentary pharmacology & therapeutics·2014
    Same author

    Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis.

    Alimentary pharmacology & therapeutics·2014
    Same author

    Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.

    Alimentary pharmacology & therapeutics·2014

    Antinuclear antibody (ANA) positive chronic active hepatitis shares some lab markers with systemic lupus erythematosus (SLE), but differs significantly in clinical presentation, despite immunologic similarities.

    Area of Science:

    • Hepatology
    • Immunology
    • Rheumatology

    Background:

    • Chronic active hepatitis (CAH) can present with autoimmune features.
    • Antinuclear antibody (ANA) positivity is observed in some patients with hepatitis B surface antigen-negative CAH.
    • Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with diverse clinical manifestations.

    Purpose of the Study:

    • To evaluate the clinical similarity between ANA-positive CAH and SLE.
    • To determine if laboratory similarities translate to overlapping clinical features.

    Main Methods:

    • Retrospective review of 89 patients with hepatitis B surface antigen-negative, ANA-positive severe CAH.
    • Assessment of clinical features suggestive of SLE.
    • Application of the 1971 and 1982 American Rheumatism Association (ARA) classification criteria for SLE.

    Related Experiment Videos

    Main Results:

    • While immunologic abnormalities (e.g., anti-native DNA antibodies, positive lupus erythematosus cell preparations) were common, few patients exhibited SLE-specific clinical features.
    • The 1971 ARA criteria showed 93% specificity for SLE in this cohort.
    • The 1982 ARA criteria demonstrated 91% specificity for SLE.

    Conclusions:

    • ANA-positive CAH and SLE exhibit significant differences in clinical presentation, despite shared immunological markers.
    • Laboratory findings alone are insufficient to equate ANA-positive CAH with SLE.
    • Distinguishing between these conditions is crucial for appropriate patient management and treatment.